| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | 26.516 | 59.858 | 59.005 | 41.517 | - |
| Total Income - EUR | - | - | - | - | - | 26.519 | 59.858 | 59.005 | 41.517 | - |
| Total Expenses - EUR | - | - | - | - | - | 15.987 | 22.582 | 40.306 | 38.357 | - |
| Gross Profit/Loss - EUR | - | - | - | - | - | 10.533 | 37.276 | 18.699 | 3.160 | - |
| Net Profit/Loss - EUR | - | - | - | - | - | 10.205 | 36.749 | 18.198 | 2.807 | - |
| Employees | - | - | - | - | - | 2 | 2 | 2 | 2 | - |
Check the financial reports for the company - Alesimed-Pak S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | 0 | 0 | 30.273 | 20.393 | - |
| Current Assets | - | - | - | - | - | 12.613 | 49.834 | 67.458 | 77.179 | - |
| Inventories | - | - | - | - | - | 0 | 0 | 151 | 151 | - |
| Receivables | - | - | - | - | - | 0 | 49.527 | 63.285 | 74.706 | - |
| Cash | - | - | - | - | - | 12.613 | 307 | 4.021 | 2.322 | - |
| Shareholders Funds | - | - | - | - | - | 10.246 | 46.768 | 65.110 | 67.282 | - |
| Social Capital | - | - | - | - | - | 41 | 40 | 41 | 40 | - |
| Debts | - | - | - | - | - | 2.367 | 3.066 | 32.667 | 30.337 | - |
| Income in Advance | - | - | - | - | - | 0 | 0 | 0 | 0 | - |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4120 - 4120" | |||||||||
| CAEN Financial Year |
4120
|
|||||||||
Comments - Alesimed-Pak S.r.l.